Search clinical trials for: H5N1 influenza pandemic

Total 4093 results

MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Healthy | Influenza

United States
Tel-Aviv Sourasky Medical Center

Terminated

The Effect of Rituximab on the Humoral Response to Influenza Vaccine

Rheumatoid Arthritis
Boston Children's Hospital
Centers for Disease Control and Prevention

Completed

Electronic Health Records for Health Promotion

Influenza

United States
National Taiwan University Hospital

Unknown

Correlation of 6-Minute Walk Test and Neuromuscular Parameters in the Elderly

Healthy

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Gram-Positive Bacterial Infections | Klebsiella Infections | Escherichia Coli Infections

Korea, Republic of
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Influenza

Germany
Assistance Publique - Hôpitaux de Paris

Terminated

Influenza Vaccination of Nursing Home Workers.

Influenza Disease

France
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
PowderMed

Completed

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

Influenza

United States
University of Texas Southwestern Medical Center
Biogen

Completed

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

Multiple Sclerosis

United States
ID Biomedical Corporation, Quebec

Completed

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Influenza

United States
The Cleveland Clinic

Completed

Influenza Vaccination in Bone Marrow Transplantation

Influenza

United States
Probiomics Ltd

Unknown

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Influenza

Australia
Ministry of Health, Israel

Unknown

A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family

Influenza
ID Biomedical Corporation, Quebec

Unknown

Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

Influenza

United States
The Cleveland Clinic

Completed

Improving Influenza Vaccination Rates Among Health Care Professionals

Influenza

United States
University Hospital, Antwerp
Universiteit Antwerpen; Eurogenerics NV

Completed

Effectiveness of Influenza Vaccination Among General Practitioners

Influenza
Hadassah Medical Organization

Completed

Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy

Influenza

Israel
Solvay Pharmaceuticals

Completed

Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China

Healthy

China
University of Shizuoka
White Cross Nursing Home; Seirei Hamamatsu General Hospital; Shizuoka General...

Completed

Catechin Gargling for Influenza Infection

Influenza Infection

Japan
MedImmune LLC

Completed

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children

Respiratory Tract Infections

Spain, Israel
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older

Influenza

South Africa
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma

Asthma

Belgium
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children

Healthy

Philippines, Thailand
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children

Healthy

China
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.

Influenza
Louisiana State University Health Sciences Center...
Centers for Disease Control and Prevention

Unknown

Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department

High Risk for Serious Influenza | High Risk for Pneumonia

United States
The New York Academy of Medicine

Unknown

Rapid Vaccination of Hard-To-Reach Populations

Influenza

United States
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Influenza

Finland
Novartis
Novartis Vaccines; Chiron s.r.l. Beijing Representative Office

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza

China
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Follow-Up of VLBW Infants With Chronic Lung Disease: Respiratory Health and Neurodevelopment

Premature Birth

Taiwan
Hospital Clinic of Barcelona

Completed

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

HIV

Spain
University of Michigan

Completed

Memory for Flu Facts and Myths and Effects on Vaccine Intentions

Influenza Vaccines

United States, Canada
London School of Hygiene and Tropical Medicine
Medical Research Council; National Malaria Control Programme, The Gambia

Completed

Lapdap and Coartemether for Uncomplicated Malaria

Malaria

Gambia
Catalan Institute of Health

Completed

Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy

Influenza

Spain
University Of Perugia

Completed

Influenza Vaccination and Oral Anticoagulant Therapy

Influenza Vaccines | Anticoagulants

Italy
Association Européenne de Recherche en Oncologie
Roche Pharma AG

Unknown

Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy

Colorectal Cancer

France
Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases (NIAID); Alaska Native... and other collaborators

Completed

Study to Eliminate Hib Carriage in Rural Alaska Native Villages

Haemophilus Influenzae Type B | Carrier State

United States

3

Subscribe